Tab Application Banner
  • Users Online: 394
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2013  |  Volume : 8  |  Issue : 6  |  Page : 24-28

Outcome assessment in psoriatic arthritis


1 Institute of Rheumatic and Musculoskeletal Medicine, Leeds Institute of Molecular Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, UK
2 Department of Medicine, Division of Rheumatology, University of Toronto; Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

Correspondence Address:
Vinod Chandran
Department of Medicine, Division of Rheumatology, University of Toronto; Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1016/j.injr.2013.11.007

Rights and Permissions

The wide spectrum of manifestations of psoriatic arthritis (PsA) makes the standardized assessment of the disease difficult. Outcome measures used in clinical trials so far have been borrowed from that used in rheumatoid arthritis. These measures, such as the EULAR response criteria have been shown to perform well in psoriatic peripheral polyarthritis. These measures may however not perform well in PsA presenting predominantly as oli- goarthritis, axial arthritis, enthesitis or dactylitis. The Group for Research and Assessment of Psoriasis and PsA along with OMERACT has been actively working towards developing validated and feasible measures for the assessment PsA. The first outcome measures workshop in PsA was held at OMERACT 7, and consensus on core domain set for PsA was obtained at OMERACT 8. Subsequently, a few composite indices for the assessment of PsA have been developed and need validation. This article reviews the challenges inherent in the assessment of PsA, the work done by OMERACT and GRAPPA to date, and the future research agenda.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed716    
    Printed17    
    Emailed0    
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal